Whether you accept it, avoid it or live somewhere in between, insurance coverage has become a defining issue for our profession. Patients increasingly expect to use their benefits, practitioners want to be compensated fairly for their time and expertise, and the system itself remains – at best – fragmented. The encouraging news is that coverage has expanded in meaningful ways. The challenging news is that reimbursement, across the board, remains inadequate.
Ajay Goel, PhD, AGAF
Dr. Ajay Goel is a professor and chair of Department of Translational Genomics and Oncology at the Beckman Research Institute City of Hope Comprehensive Cancer Center, and director of Biotech Innovations at the City of Hope Medical Center, in Duarte, Calif. He has also been recognized as an American Gastrointestinal Association Fellow (AGAF) for his research on colorectal cancer. In fact, Dr. Goel has spent more than 20 years researching cancer and has been the lead author or contributor to over 300 scientific articles published in peer-reviewed international journals, as well as several book chapters. He is currently researching the prevention of GI cancers using integrative and alternative approaches, including botanical products. Three of the primary botanicals he is investigating are curcumin (from turmeric), boswellia and French grape seed. For inquiries regarding his research, contact him at ajgoel@coh.org.